Inotek Pharmaceuticals Corp (ITEK): Billionaire Ken Griffin’ Citadel Investment Group Raises Stake to 6.5%

Page 10 of 10

Page 10 of 10 – SEC Filing

After reasonable inquiry
and to the best of its knowledge and belief, the undersigned certify that the information set forth in this statement is true,
complete and correct.

Dated this 29th day of August, 2016.

CITADEL ADVISORS LLC CITADEL ADVISORS HOLDINGS II LP
By: /s/ Mark Polemeni By: /s/ Mark Polemeni
Mark Polemeni, Authorized Signatory Mark Polemeni, Authorized Signatory
CITADEL GP LLC KENNETH GRIFFIN
   
By: /s/ Mark Polemeni By: /s/ Mark Polemeni
Mark Polemeni, Authorized Signatory Mark Polemeni,
attorney-in-fact*
* Mark Polemeni is signing on behalf of Kenneth Griffin as attorney-in-fact pursuant to a power of attorney previously filed
with the Securities and Exchange Commission on January 18, 2013, and hereby incorporated by reference herein. The power of attorney
was filed as an attachment to a filing by Citadel Advisors LLC on Schedule 13G for TiVo Inc.

Follow Rocket Pharmaceuticals Inc. (NASDAQ:RCKT)

Page 10 of 10